严重的anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic酸受体脑炎与长期的高氨血症:一个病例报告
Chunxia Yan1, Lingling Bai1, Jingwei Du1
1Department of Neurology, Liaocheng People ' s Hospital, No. 45 Huashan Road, Economic Development Zone, Liaocheng, Shandong, 252000, China.
严重的anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic酸受体脑炎 (Anti-AMPAR-E) 与高血是罕见的. 早期瘤查和氨水平监测对于管理这种情况和改善患者的治疗结果至关重要.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 抗α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic酸受体脑炎 (Anti-AMPAR-E) 是一种罕见的自身免疫性脑炎.
- 它通常表现为记忆力下降,发作,精神病和行为变化,通常与瘤有关,并带来不良预后.
- 患有高氨血症的严重病例非常罕见.
研究的目的:
- 报告一种罕见的严重抗AMPAR-E病例与长期的高氨血.
- 突出瘤查和这些患者氨水平管理的重要性.
主要方法:
- 一个66岁的男性患有记忆力下降和困惑的案例介绍.
- 诊断证实了血清和脑脊液中AMPAR抗体的阳性,以及氨水平的升高.
- 治疗包括IVMP,IVIG和rituximab治疗.
主要成果:
- 患者经历了一段激烈的过程,进展到昏迷2个月.
- 在接受治疗后,他恢复了意识,但后来被诊断出患有肺癌.
- 病人最终在家中去世.
结论:
- 对于患有严重抗AMPAR-E的患者来说,定期瘤查至关重要,以早期检测瘤.
- 为了改善长期结果,需要重复评估氨水平,并适当治疗高氨血症.
更多相关视频
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
